Severe Asthma Endotypes: A Test on Features, Assessment & Treatment

How familiar are you with mechanistic features of severe asthma, specific biomarker level cut offs, and impact of comorbid disease on choice of biologic treatment?

Consideration of the specific mechanistic pathway that underlies a presentation of severe asthma is one key factor in choosing the appropriate biologic treatment as are investigation of biomarker levels and evaluation of comorbid inflammatory disease.

Following are 5 questions on these topics that are based on a comprehensive review and international expert opinion published this month in the Journal of Allergy and Clinical Immunology: In Practice by a group of experts recognized for knoweldge of severe asthma and of biologic medications.

Test your endotype IQ!